Loading your page…
Marketing-authorisation holder · Germany
28 medicines in 5 countries, as authorisation holder and manufacturer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
1–25 of 28
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GalliaPharm | Gallium (67 ga) citrate, Germanium | EU (EMA) | Authorised | 2024 |
| GALLIAPHARMGeneratore di radionuclidi | Germanium, Gallium (67 ga) citrate | Italy | Authorised | |
| GALLIAPHARM1.85 gbq / gen · Solution | Gallium (67 ga) citrate | Canada | Marketed | 2023 |
| GALLIAPHARM 0,74 - 1,85 GBq GENERADOR DE RADIONUCLIDO0 - + 0,74 - 1,85 GBq · Generador de radionúclido | Gallium (67 ga) citrate, Germanio cl | Spain | Marketed | 2014 |
| GALLIAPHARM 1,11 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 1,11 GIGABECQUERELIOS + Aproximadamente igual a 1,11 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 1,11 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 1,48 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 1,48 GIGABECQUERELIOS + Aproximadamente igual a 1,48 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 1,48 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 1,85 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 1,85 GIGABECQUERELIOS + Aproximadamente igual a 1,85 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 1,85 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 2,22 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 2,22 GIGABECQUERELIOS + Aproximadamente igual a 2,22 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 2,22 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 2,59 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 2,59 GIGABECQUERELIOS + Aproximadamente igual a 2,59 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 2,59 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 2,96 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 2,96 GIGABECQUERELIOS + Aproximadamente igual a 2,96 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 2,96 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 3,33 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 3,33 GIGABECQUERELIOS + Aproximadamente igual a 3,33 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 3,33 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| GALLIAPHARM 3,70 GBQ GENERADOR DE RADIONUCLIDOSAproximadamente igual a 3,70 GIGABECQUERELIOS + Aproximadamente igual a 3,70 GIGABECQUERELIOS · Generador de radionúclido | Germanio cl, Gallium (67 ga) citrate | Spain | Marketed | 2024 |
| GalliaPharm 3,70 GBq radionuclidegeneratorRadionuclide generator | Germanium tetrachloride, gallium trichloride | Netherlands | Authorised | 2024 |
| Theralugand | Lutetium | EU (EMA) | Authorised | 2024 |
| THERALUGANDPrecursore di radionuclidi, soluzione | Lutezio | Italy | Authorised | |
| Theralugand 40 GBq/ml radiofarmaceutische uitgangsstof, oplossingRadiofarmaceutische uitgangsstof | Lutetium(177 lu)oxodotreotide | Netherlands | Authorised | 2024 |
| YTTRIGA300 gbq / vial · Solution | Yttrium (90 y) citrate colloid | Canada | Not marketed | 2018 |
| YTTRIGAPrecursore radiofarmaceutico | Yttrium (90 y) citrate colloid | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 11 | 11 | 0 | CompaniesAll medicines |
| Netherlands | 10 | 10 | 0 | CompaniesAll medicines |
| Italy | 3 | 3 | 0 | CompaniesAll medicines |
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, France, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
